
National Research Corporation NRC
$ 17.62
-1.23%
Annual report 2025
added 03-05-2026
National Research Corporation P/B Ratio 2011-2026 | NRC
Annual P/B Ratio National Research Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.5 | 10.7 | 20.6 | 15.8 | 12.4 | 17.6 | 52.2 | 55.7 | 9.98 | 5.03 | 4.92 | 3.83 | 5.21 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 55.7 | 3.83 | 18.2 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
7.78 | $ 118.25 | -1.27 % | $ 35.9 B | ||
|
Burning Rock Biotech Limited
BNR
|
1.22 | $ 22.5 | 9.44 % | $ 242 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 22.42 | 27.6 % | $ 1.19 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
0.284 | $ 1.46 | 2.82 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 24.56 | -0.24 % | $ 682 M | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 176.94 | -2.0 % | $ 8.77 B | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 515.65 | -0.56 % | $ 14.9 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
1.79 | $ 193.78 | -2.18 % | $ 138 B | ||
|
Interpace Biosciences
IDXG
|
0.328 | $ 2.2 | - | $ 9.73 M | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
1.77 | $ 8.16 | -5.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.24 | -1.91 % | $ 2 B | ||
|
Illumina
ILMN
|
2.6 | $ 132.72 | 0.35 % | $ 21.1 B | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 16.13 | -0.25 % | $ 488 M | ||
|
Koninklijke Philips N.V.
PHG
|
0.995 | $ 28.63 | -1.58 % | $ 20 B | ||
|
Guardant Health
GH
|
-135 | $ 85.7 | 0.99 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
0.00742 | $ 2.83 | -3.41 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
1.75 | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Senseonics Holdings
SENS
|
5.74 | $ 6.77 | -1.88 % | $ 282 M | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 115.58 | -0.79 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 266.36 | -0.14 % | $ 22.2 B | ||
|
Soleno Therapeutics
SLNO
|
4.63 | $ 52.57 | - | $ 2.67 B | ||
|
Motus GI Holdings
MOTS
|
0.368 | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
53.4 | $ 125.25 | 1.44 % | $ 5.86 B | ||
|
Neuronetics
STIM
|
3.09 | $ 1.4 | 0.72 % | $ 92.3 M | ||
|
Myriad Genetics
MYGN
|
1.11 | $ 5.0 | -3.66 % | $ 463 M | ||
|
Lantheus Holdings
LNTH
|
4.7 | $ 83.92 | -0.02 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
1.78 | $ 516.0 | -2.95 % | $ 195 B | ||
|
Trinity Biotech plc
TRIB
|
-375 | $ 0.7 | -0.54 % | $ 61.9 M | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 191.46 | 0.02 % | $ 21.3 B | ||
|
ENDRA Life Sciences
NDRA
|
1.62 | $ 5.17 | 0.58 % | $ 4.07 M | ||
|
Twist Bioscience Corporation
TWST
|
3.31 | $ 56.23 | -2.41 % | $ 3.36 B |